<--- Back to Details
First PageDocument Content
Fabry disease / Alpha-galactosidase / Genzyme / Enzyme replacement therapy / Amyotrophic lateral sclerosis / Rare diseases / Health / Lipid storage disorders
Date: 2012-02-26 16:46:11
Fabry disease
Alpha-galactosidase
Genzyme
Enzyme replacement therapy
Amyotrophic lateral sclerosis
Rare diseases
Health
Lipid storage disorders

CFA Members GenzymeShortage

Add to Reading List

Source URL: www.fabrycanada.com

Download Document from Source Website

File Size: 225,04 KB

Share Document on Facebook

Similar Documents

Health / Genzyme / Sanofi / Medicine / Fabry disease / Alpha-galactosidase / Clinical medicine / Lawsuit

United States Court of Appeals For the First Circuit NoANITA HOCHENDONER ET AL., Plaintiffs, Appellants, v.

DocID: 1rtqA - View Document

Sanofi / Economy of France / Business / CAC 40 / Economy / Epinephrine autoinjector / Merial / Genzyme / SNY

PRESS RELEASE For Canadian media only Sanofi to Return Allerject® (epinephrine injection, USP) Rights to kaléo Laval, Qc. - February 23, Sanofi (EURONEXT : SAN and NYSE : SNY) announced today

DocID: 1rewx - View Document

genzyme_anzeige_290x60_2014-02-07_D_v02_em.indd

DocID: 1pkK1 - View Document

United States patent law / BioMarin Pharmaceutical / Genzyme / Glycogen storage disease type II / Inter partes review / Pharmaceutical drug / Reexamination / Patent Trial and Appeal Board / Inter partes / Iduronidase

United States Court of Appeals for the Federal Circuit ______________________ GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP,

DocID: 1oYEH - View Document

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE GENZYME CORPORATION and SANOFI-AVENTIS U.S. LLC, Plaintiffs/Counterclaim-Defendants, Plaintiffs,

DocID: 1omGa - View Document